Search research articles
Contact Us
Filters
Showing results (21-30 of 40) with videos related to
Page
of 4
Sort By:
The Journal of Infectious Diseases
|
April 4, 2017
Plasma MicroRNA Levels Are Associated With Hepatitis B e Antigen Status and Treatment Response in Chronic Hepatitis B Patients
Meike H van der Ree, Louis Jansen, Zita Kruize, et al.
Therapeutic Advances in Medical Oncology
|
August 27, 2025
Tissue factor expression in salivary gland carcinoma: a potential novel therapeutic target for advanced disease
Louis Jansen, Lisa Nachtsheim, Philipp Wolber, et al.
The Journal of Infectious Diseases
|
March 21, 2015
Natural Killer Cell Characteristics in Patients With Chronic Hepatitis B Virus (HBV) Infection Are Associated With HBV Surface Antigen Clearance After Combination Treatment With Pegylated Interferon Alfa-2a and Adefovir
Femke Stelma, Annikki de Niet, Marjan J Tempelmans Plat-Sinnige, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
October 14, 2025
Deciphering the cellular tumor microenvironment landscape in salivary gland carcinomas using multiplexed imaging mass cytometry
Marcel Mayer, Lisa Nachtsheim, Louis Jansen, et al.
Antiviral Research
|
July 30, 2017
Viral minority variants in the core promoter and precore region identified by deep sequencing are associated with response to peginterferon and adefovir in HBeAg negative chronic hepatitis B patients
Louis Jansen, Matthijs R A Welkers, Karel A van Dort, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 31, 2025
Incidence and survival of primary major salivary gland carcinoma in Germany over the last decade: A nationwide population-based study
Louis Jansen, Marcel Mayer, Andreas Stang, et al.
Journal of Clinical and Experimental Hepatology
|
June 9, 2022
A Prospective Five-Year Follow-up After peg-Interferon Plus Nucleotide Analogue Treatment or no Treatment in HBeAg Negative Chronic Hepatitis B Patients
Robin Erken, Vladimir V Loukachov, Annikki de Niet, et al.
HNO
|
January 21, 2026
[Role of human papillomavirus vaccination in prevention of oropharyngeal cancer and recommendations for patients and relatives]
Sofia Kourou, Charles Schmit, Louis Jansen, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
December 24, 2014
An intrahepatic transcriptional signature of enhanced immune activity predicts response to peginterferon in chronic hepatitis B
Louis Jansen, Annikki de Niet, Zuzanna Makowska, et al.
Journal of Hepatology
|
October 28, 2015
Restoration of T cell function in chronic hepatitis B patients upon treatment with interferon based combination therapy
Annikki de Niet, Femke Stelma, Louis Jansen, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 40) with videos related to
Sort By:
Page
of 4
The Journal of Infectious Diseases
|
April 4, 2017
Plasma MicroRNA Levels Are Associated With Hepatitis B e Antigen Status and Treatment Response in Chronic Hepatitis B Patients
Meike H van der Ree, Louis Jansen, Zita Kruize, et al.
Therapeutic Advances in Medical Oncology
|
August 27, 2025
Tissue factor expression in salivary gland carcinoma: a potential novel therapeutic target for advanced disease
Louis Jansen, Lisa Nachtsheim, Philipp Wolber, et al.
The Journal of Infectious Diseases
|
March 21, 2015
Natural Killer Cell Characteristics in Patients With Chronic Hepatitis B Virus (HBV) Infection Are Associated With HBV Surface Antigen Clearance After Combination Treatment With Pegylated Interferon Alfa-2a and Adefovir
Femke Stelma, Annikki de Niet, Marjan J Tempelmans Plat-Sinnige, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
October 14, 2025
Deciphering the cellular tumor microenvironment landscape in salivary gland carcinomas using multiplexed imaging mass cytometry
Marcel Mayer, Lisa Nachtsheim, Louis Jansen, et al.
Antiviral Research
|
July 30, 2017
Viral minority variants in the core promoter and precore region identified by deep sequencing are associated with response to peginterferon and adefovir in HBeAg negative chronic hepatitis B patients
Louis Jansen, Matthijs R A Welkers, Karel A van Dort, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 31, 2025
Incidence and survival of primary major salivary gland carcinoma in Germany over the last decade: A nationwide population-based study
Louis Jansen, Marcel Mayer, Andreas Stang, et al.
Journal of Clinical and Experimental Hepatology
|
June 9, 2022
A Prospective Five-Year Follow-up After peg-Interferon Plus Nucleotide Analogue Treatment or no Treatment in HBeAg Negative Chronic Hepatitis B Patients
Robin Erken, Vladimir V Loukachov, Annikki de Niet, et al.
HNO
|
January 21, 2026
[Role of human papillomavirus vaccination in prevention of oropharyngeal cancer and recommendations for patients and relatives]
Sofia Kourou, Charles Schmit, Louis Jansen, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
December 24, 2014
An intrahepatic transcriptional signature of enhanced immune activity predicts response to peginterferon in chronic hepatitis B
Louis Jansen, Annikki de Niet, Zuzanna Makowska, et al.
Journal of Hepatology
|
October 28, 2015
Restoration of T cell function in chronic hepatitis B patients upon treatment with interferon based combination therapy
Annikki de Niet, Femke Stelma, Louis Jansen, et al.
Page
of 4